Safety of retreatment with immunotherapy after immune-related toxicity in patients with lung cancers treated with anti-PD(L)-1 therapy.-MedSci.cn

Safety of retreatment with immunotherapy after immune-related toxicity in patients with lung cancers treated with anti-PD(L)-1 therapy.

Santini, FC; Rizvi, H; Wilkins, O; van Voorthuysen, M; Panora, E; Halpenny, D; Kris, MG; Rudin, CM; Chaft, JE; Hellmann, MD

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):

科室
- - 订阅+
  - 更多科室
工具
服务